上海交通大学生物学博士。8年医药行业产业研究工作经验。深度覆盖中药行业9年,2024Choice最佳分析师、2021金麒麟未来之星。清华大学生物学博士,药学院博士后。重点覆盖创新药、医药外包龙头、原料药及仿制药领域。创新药创新药2026年度策略:看好工程师红利下创新突围01国际化:工程师红利兑现期,全球重估1、股价:数据催化&BD驱动更突出。A股(2024.12.31-2025.11.14)...
Source Link上海交通大学生物学博士。8年医药行业产业研究工作经验。深度覆盖中药行业9年,2024Choice最佳分析师、2021金麒麟未来之星。清华大学生物学博士,药学院博士后。重点覆盖创新药、医药外包龙头、原料药及仿制药领域。创新药创新药2026年度策略:看好工程师红利下创新突围01国际化:工程师红利兑现期,全球重估1、股价:数据催化&BD驱动更突出。A股(2024.12.31-2025.11.14)...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.